Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy.
Jiayue QiuXiangmei LiYalan HeQian WangJi LiJiashuo WuYing JiangJunwei HanPublished in: Journal of translational medicine (2022)
was demonstrated to be an effective predictor of immunotherapeutic benefit in seven independent immunotherapy cohorts and may serve as a potential and convenient biomarker for the clinical application of ICB therapy.